Literature DB >> 18346402

Endothelin-3 is produced by metastatic melanoma cells and promotes melanoma cell survival.

Liren Tang1, Mingwan Su, Yi Zhang, Wency Ip, Magdalena Martinka, Changzheng Huang, Youwen Zhou.   

Abstract

BACKGROUND: Endothelin-3 (ET-3) is an essential paracrine factor for the proliferation, migration, and survival of embryonic melanocytes during fetal development. Its expression is tightly regulated, being completely turned off in adult skin.
OBJECTIVE: In this study, results are presented that demonstrate abnormal expression of ET-3 by metastatic melanoma cells in both tissue biopsies and cell culture. Further, in vitro experiments showed that metastatic melanoma cells have the capacity to respond to ET-3 stimulation by increasing survival.
CONCLUSION: Therefore, an abnormal autocrine stimulation pathway involving ET-3 is present in metastatic melanoma cells. Blocking this signal transduction pathway may prove useful for the treatment of metastatic melanoma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18346402     DOI: 10.2310/7750.2008.06164

Source DB:  PubMed          Journal:  J Cutan Med Surg        ISSN: 1203-4754            Impact factor:   2.092


  13 in total

1.  Rendomab B4, a monoclonal antibody that discriminates the human endothelin B receptor of melanoma cells and inhibits their migration.

Authors:  Aurélie Borrull; Bertrand Allard; Anne Wijkhuisen; Amaury Herbet; Patricia Lamourette; Wided Birouk; Denis Leiber; Zahra Tanfin; Frédéric Ducancel; Didier Boquet; Jean-Yves Couraud; Philippe Robin
Journal:  MAbs       Date:  2016-07-08       Impact factor: 5.857

Review 2.  Endothelin 1 in cancer: biological implications and therapeutic opportunities.

Authors:  Laura Rosanò; Francesca Spinella; Anna Bagnato
Journal:  Nat Rev Cancer       Date:  2013-07-25       Impact factor: 60.716

3.  Silencing endothelin-3 expression attenuates the malignant behaviors of human melanoma cells by regulating SPARC levels.

Authors:  Xiang-Jie An; Yan-Qiu Li; Xiao-Ying Qu; Jing Zhang; Ling-Yun Zhang; Ming Wang; Li Zhu; Si-Yuan Chen; Hong-Xiang Chen; Ya-Ting Tu; Yu-Wen Zhou; Chang-Zheng Huang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-08-01

4.  Biomarkers: the useful and the not so useful--an assessment of molecular prognostic markers for cutaneous melanoma.

Authors:  Bonnie E Gould Rothberg; David L Rimm
Journal:  J Invest Dermatol       Date:  2010-06-17       Impact factor: 8.551

5.  Inhibition of endothelin-B receptor signaling synergizes with MAPK pathway inhibitors in BRAF mutated melanoma.

Authors:  Alexander Schäfer; Benedicte Haenig; Julie Erupathil; Panja Strickner; Daniela Sabato; Richard W D Welford; Lhéanna Klaeylé; Elise Simon; Clemens Krepler; Patricia Brafford; Min Xiao; Meenhard Herlyn; Matthias Gstaiger; Francois Lehembre; Imke Renz
Journal:  Oncogene       Date:  2021-01-26       Impact factor: 9.867

Review 6.  Roles of endothelin signaling in melanocyte development and melanoma.

Authors:  Amy Saldana-Caboverde; Lidia Kos
Journal:  Pigment Cell Melanoma Res       Date:  2010-02-01       Impact factor: 4.693

Review 7.  Malignant melanoma in the 21st century: the emerging molecular landscape.

Authors:  Aleksandar Sekulic; Paul Haluska; Arlo J Miller; Josep Genebriera De Lamo; Samuel Ejadi; Jose S Pulido; Diva R Salomao; Erik C Thorland; Richard G Vile; David L Swanson; Barbara A Pockaj; Susan D Laman; Mark R Pittelkow; Svetomir N Markovic
Journal:  Mayo Clin Proc       Date:  2008-07       Impact factor: 7.616

Review 8.  Developmental pathways activated in melanocytes and melanoma.

Authors:  Jianglan Liu; Mizuho Fukunaga-Kalabis; Ling Li; Meenhard Herlyn
Journal:  Arch Biochem Biophys       Date:  2014-08-08       Impact factor: 4.013

9.  Eyes absent gene (EYA1) is a pathogenic driver and a therapeutic target for melanoma.

Authors:  Joshua Jiawei Zhou; Yuanshen Huang; Xue Zhang; Yabin Cheng; Liren Tang; Xiaodong Ma
Journal:  Oncotarget       Date:  2017-09-27

10.  Identification of key genes associated with cervical cancer by comprehensive analysis of transcriptome microarray and methylation microarray.

Authors:  Ming-Yan Liu; Hong Zhang; Yuan-Jing Hu; Yu-Wei Chen; Xiao-Nan Zhao
Journal:  Oncol Lett       Date:  2016-06-01       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.